STAT3 and neoplasm: Constitutive STAT3 activation in tumor-residing DCs reduces expression of MHC class II and costimulatory molecules, impairs the antigen-presenting function of DC and contributes to the expansion of tumor-infiltrating FOXP3+ T-cells and attenuates CD4+ Th cell responses [117,122,123].